Waisman Center
Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.

An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease

Hagemann, PhD, T. L., and A. Messing, VMD, PhD. An In Vivo Pharmacological Screen Identifies Cholinergic Signaling As a Therapeutic Target in Glial-Based Nervous System Disease.

Wang L, Hagemann TL, Messing A, Feany MB. (2016) An In Vivo Pharmacological Screen Identifies Cholinergic Signaling as a Therapeutic Target in Glial-Based Nervous System Disease. Journal of Neuroscience. 3;36(5):1445-55. doi: 10.1523/JNEUROSCI.0256-15.2016.